Synthesis and characterization of some hydroxypyridone derivatives and their evaluation as antimicrobial agents

References

• Faid-Allah HM, Al-Saadi MS, Rostom ShAF. Synthesis of new coumarin-3-carbonylurea, thiourea analogs and some derived ring systems of possible therapeutic interest. J Saudi Chem Soc (JSCS) 2003;7:367–372.
   Google Scholar
• Al-Saadi MSM, Rostom ShAF, Faid-Allah HM. In vitro antitumor screening of some polysubstituted pyrazole analogs. Saudi Pharm J (SPJ) 2005;13:89–96.
   Google Scholar
• Al-Saadi MSM, Rostom ShAF, Faid-Allah HM. Synthesis and biological evaluation of some 3-cyano-4-(1-methyl-1H-pyrrol-2-yl)-6-substituted-2(1H)-pyridinones and their 2-imino isosters. Alex J Pharm Sci 2005;19:15–21.
   Google Scholar
• Faid-Allah HM, Al-Saadi MS, Rostom ShAF, Fahmy HT. Synthesis of some sulfonamides, disubstituted sulfonylureas or thioureas and some structurally related variants. A class of promising antitumor agents. Med Chem Res 2007;16:300–318.
   Web of Science ®Google Scholar
• Al-Saadi MS, Rostom SA, Faidallah HM. 3-methyl-2-(4-substituted phenyl)-4,5-dihydronaphtho[1,2-c]-pyrazoles: synthesis and in vitro biological evaluation as antitumour agents. Arch Pharm (Weinheim) 2008;341:181–190.
   PubMed Web of Science ®Google Scholar
• Faid-Allah HM, Al-Saadi MS, Rostom ShAF. Synthesis and biological evaluation of certain 2H-pyran-2-ones and some derived 1H-pyridin-2-one analogs as antimicrobial agents. Saudi Pharm J (SPJ) 2008;16:33–42.
   Google Scholar
• Al-Saadi MSM, Faid-Allah HM, Rostom ShAF. Synthesis and biological evaluation of some 2,4,5-trisubstituted thiazole derivatives as potential antimicrobial and anticancer agents. Arch Pharm Chem Life Sci 2008;341:424–434.
   PubMed Web of Science ®Google Scholar
• Rostom ShAF, Faidallah HM, Al Saadi MSM. A Facile synthesis of some 3- cyano-1,4,6-trisubstituted-2-(1H)-pyridines and their biological evaluation as anticancer agents. Med Chem Res 2011;20:1260–1272.
   Web of Science ®Google Scholar
• Faidallah HM, Khan KA, Asiri AM. Synthesis and biological evaluation of new 3-trifluoromethyl-pyrazolesulfonylurea and thiourea derivatives as antidiabetic and antimicrobial agents. J Fluorine Chem 2011;132:131–137.
   Web of Science ®Google Scholar
• Faidallah HM, Khan KA, Asiri AM. Synthesis and characterization of a novel series of benzenesulfonylurea and thiourea derivatives of 2H-pyran and 2H-pyridine-2-ones as antibacterial, antimycobacterial and antifungal agents. Eur J Chem 2011;2:243–250.
   Google Scholar
• Faidallah HM, Khan KA, Asiri AM. Synthesis and biological evaluation of new 3,5-di(trifluoromethyl)-1,2,4-triazoles-ulfonylurea and thiourea derivatives as antidiabetic and antimicrobial agents. J Fluorine Chem 2011;132:870–877.
   Web of Science ®Google Scholar
• Aanandhi MV, George S, Vaidhyalingam V. Synthesis and antimicrobial activities of 1-(5-substituted-2-oxoindolin-3-ylidene)-4-(substituted pyridin-2-yl)thiosemicarbazide. ARKIVOC 2008;(xi):187–194.
   Google Scholar
• Narayana BL, Rao ARR, Rao PS. Synthesis of new 2-substituted pyrido[2,3-d]pyrimidin-4(1H)-ones and their antibacterial activity. Eur J Med Chem 2009;44: 1369–1376.
   PubMed Web of Science ®Google Scholar
• Ranft D, Seyfarth T, Schaper K-J, Lehwark-Yvetot G, Bruhn C, Buege A. New N1-hetarylmethylene-substituted amidrazones with potential antimycobacterial activity. Arch der Pharm-Chem Life Sci 1999;332:427–430.
   Web of Science ®Google Scholar
• Khoshneviszadeh M, Edraki N, Javidnia K, Alborzi A, Pourabbas B, Mardaneh J et al. Synthesis and biological evaluation of some new 1,4-dihydropyridines containing different ester substitute and diethyl carbamoyl group as anti-tubercular agents. Bioorg Med Chem 2009;17:1579–1586.
   PubMed Web of Science ®Google Scholar
• Abid M, Husain K, Azam A. Synthesis and antiamoebic activity of new oxime ether derivatives containing 2-acetylpyridine/2-acetylfuran. Bioorg Med Chem Lett 2005;15:4375–4379.
   PubMed Web of Science ®Google Scholar
• Saudi MNS, El-Sayed MH, Abou El-Hoda M. 3-Cyanopyridine derivatives: novel fasciolicidal candidates. Alex J Pharm Sci 2002;16:75–82.
   Google Scholar
• Goebel T, Ulmer D, Projahn H, Kloeckner J, Heller E, Glaser M et al. In search of novel agents for therapy of tropical diseases and human immunodeficiency virus. J Med Chem 2008;51:238–250.
   PubMed Web of Science ®Google Scholar
• Rodrigues T, Guedes RC, dos Santos DJ, Carrasco M, Gut J, Rosenthal PJ et al. Design, synthesis and structure-activity relationships of (1H-pyridin-4-ylidene)amines as potential antimalarials. Bioorg Med Chem Lett 2009;19:3476–3480.
   PubMed Web of Science ®Google Scholar
• Gudmundsson KS, Johns BA, Wang Z, Turner EM, Allen SH, Freeman GA et al. Synthesis of novel substituted 2-phenylpyrazolopyridines with potent activity against herpesviruses. Bioorg Med Chem 2005;13:5346–5361.
   PubMed Web of Science ®Google Scholar
• Allen SH, Johns BA, Gudmundsson KS, Freeman GA, Boyd FL Jr, Sexton CH et al. Synthesis of C-6 substituted pyrazolo[1,5-a]pyridines with potent activity against herpesviruses. Bioorg Med Chem 2006;14:944–954.
   PubMed Web of Science ®Google Scholar
• Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D et al. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst 1991;83:757–766.
   PubMed Web of Science ®Google Scholar
• Grever MR, Schepartz SA, Chabner BA. The National Cancer Institute: cancer drug discovery and development program. Semin Oncol 1992;19:622–638.
   PubMed Web of Science ®Google Scholar
• Boyd MR, Paull KD. Practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen. Drug Rev Res 1995;34:91–109.
   Web of Science ®Google Scholar
• Conte JE, Barriere SL. (1988). Manual of Antibiotics and Infectious Disease. 1st Edition. USA: Lea and Febiger, 135–138.
   Google Scholar